Pascal and Francis Bibliographic Databases


Search results

Your search


Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV


A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 516

  • Page / 21

Selection :

  • and

Benefits in the lipid profile after substitution of abacavir for stavudine: A 48-week prospective studyGARCIA-BENAYAS, Teresa; BLANCO, Francisco; ALCOLEA, Antonio et al.AIDS research and human retroviruses. 2004, Vol 20, Num 12, pp 1289-1292, issn 0889-2229, 4 p.Article

Benefits and risks of stavudine therapy for HIV-associated neurologic complications in UgandaSACKTOR, N; NAKASUJJA, N; SKOLASKY, R. L et al.Neurology. 2009, Vol 72, Num 2, pp 165-170, issn 0028-3878, 6 p.Article

Can We Predict Neuropathy Risk before Stavudine Prescription in a Resource-Limited Setting?AFFANDI, Jacquita S; PRICE, Patricia; IMRAN, Darma et al.AIDS research and human retroviruses. 2008, Vol 24, Num 10, pp 1281-1284, issn 0889-2229, 4 p.Article

Long-term efficacy and safety of atazanavir with stavudine and lamivudine in patients previously treated with nelfinavir or atazanavirWOOD, Robin; PHANUPHAK, Praphan; GIORDANO, Michael et al.Journal of acquired immune deficiency syndromes (1999). 2004, Vol 36, Num 2, pp 684-692, issn 1525-4135, 9 p.Article

Age and height predict neuropathy risk in patients with HIV prescribed stavudineCHERRY, C. L; AFFANDI, J. S; IMRAN, D et al.Neurology. 2009, Vol 73, Num 4, pp 315-320, issn 0028-3878, 6 p.Article

Evaluation of a Systematic Substitution of Zidovudine for Stavudine-Based HAART in a Program Setting in Rural CambodiaISAAKIDIS, Petros; RAGUENAUD, Marie-Eve; PHE, Thong et al.Journal of acquired immune deficiency syndromes (1999). 2008, Vol 49, Num 1, pp 48-54, issn 1525-4135, 7 p.Article

Rate of thymidine analogue resistance mutation accumulation with zidovudine- or stavudine-based regimensKURITZKES, Daniel R; BASSETT, Roland L; HAZELWOOD, J. Darren et al.Journal of acquired immune deficiency syndromes (1999). 2004, Vol 36, Num 1, pp 600-603, issn 1525-4135, 4 p.Article

A Longitudinal Study of the Changes in Body Fat and Metabolic Parameters in a South African Population of HIV-Positive Patients Receiving an Antiretroviral Therapeutic Regimen Containing StavudineGEORGE, Jaya A; VENTER, Willem D. F; VAN DEVENTER, Hendrick E et al.AIDS research and human retroviruses. 2009, Vol 25, Num 8, pp 771-781, issn 0889-2229, 11 p.Article

Pyrimidine Nucleoside Depletion Sensitizes to the Mitochondrial Hepatotoxicity of the Reverse Transcriptase Inhibitor StavudineSETZER, Bernhard; LEBRECHT, Dirk; WALKER, Ulrich A et al.The American journal of pathology. 2008, Vol 172, Num 3, pp 681-690, issn 0002-9440, 10 p.Article

Tolerability and Effectiveness of First-Line Regimens Combining Nevirapine and Lamivudine Plus Zidovudine or Stavudine in CameroonLAURENT, Christian; BOURGEOIS, Anke; MPOUDI-NGOLE, Eitel et al.AIDS research and human retroviruses. 2008, Vol 24, Num 3, pp 393-399, issn 0889-2229, 7 p.Article

Baseline genotype as a predictor of virological failure to emtricitabine or stavudine in combination with didanosine and efavirenzBORROTO-ESODA, Katyna; WATERS, Joshua M; BAE, Andrew S et al.AIDS research and human retroviruses. 2007, Vol 23, Num 8, pp 988-995, issn 0889-2229, 8 p.Article

Real time PCR for rapid determination of susceptibility of adenovirus to antiviral drugsGAINOTTI, Rosana; RICARTE, Carmen; EBEKIAN, Beatriz et al.Journal of virological methods. 2010, Vol 164, Num 1-2, pp 30-34, issn 0166-0934, 5 p.Article

Pharmacokinetics of coadministered ritonavir-boosted elvitegravir and zidovudine, didanosine, stavudine, or abacavirRAMANATHAN, Srinivasan; GONG SHEN; HINKLE, John et al.Journal of acquired immune deficiency syndromes (1999). 2007, Vol 46, Num 2, pp 160-166, issn 1525-4135, 7 p.Article

Mitochondrial DNA Subhaplogroups L0a2 and L2a Modify Susceptibility to Peripheral Neuropathy in Malawian Adults on Stavudine Containing Highly Active Antiretroviral TherapyKAMPIRA, Elizabeth; KUMWENDA, Johnstone; VAN OOSTERHOUT, Joep J et al.Journal of acquired immune deficiency syndromes (1999). 2013, Vol 63, Num 5, pp 647-652, issn 1525-4135, 6 p.Article

Estimation of Intracellular Concentration of Stavudine Triphosphate in HIV-Infected Children Given a Reduced Dose of 0.5 Milligrams per Kilogram Twice DailySY, Sherwin K. B; INNES, Steve; DERENDORF, Hartmut et al.Antimicrobial agents and chemotherapy. 2014, Vol 58, Num 2, pp 1084-1091, issn 0066-4804, 8 p.Article

Prévalence des complications métaboliques à 10 ans de traitements antirétroviraux au Sénégal = Prevalence of metabolic complications after 10 years of antiretroviral treatment in SenegalDIOUF, A; COURNIL, A.Bulletin de la Société de pathologie exotique. 2014, Vol 107, Num 4, pp 234-237, issn 0037-9085, 4 p.Article

A clinically relevant rodent model of the HIV antiretroviral drug stavudine induced painful peripheral neuropathyWENLONG HUANG; CALVO, Margarita; KARU, Kersti et al.Pain (Amsterdam). 2013, Vol 154, Num 4, pp 560-575, issn 0304-3959, 16 p.Article

Frequency of stavudine substitution due to toxicity in children receiving antiretroviral treatment in sub-Saharan AfricaPALMER, Megan; CHERSICH, Matthew; MOULTRIE, Harry et al.AIDS (London). 2013, Vol 27, Num 5, pp 781-785, issn 0269-9370, 5 p.Article

Biowaiver Monographs for Immediate-Release Solid Oral Dosage Forms: StavudineSILVA, Arthur L. L; CRISTOFOLETTI, Rodrigo; STORPIRTIS, Silvia et al.Journal of pharmaceutical sciences. 2012, Vol 101, Num 1, pp 10-16, issn 0022-3549, 7 p.Article

Stavudine Concentrations in Women Receiving Postpartum Antiretroviral Treatment and Their Breastfeeding InfantsFOGEL, Jessica M; TAHA, Taha E; ESHLEMAN, Susan H et al.Journal of acquired immune deficiency syndromes (1999). 2012, Vol 60, Num 5, pp 462-465, issn 1525-4135, 4 p.Article

EFFECTIVENESS OF FIXED-DOSE COMBINATION STAVUDINE, LAMIVUDINE AND NEVIRAPINE (GPO-VIR) FOR TREATMENT OF NAIVE HIV PATIENTS IN THAILAND: A 3-YEAR FOLLOW-UPDESAKORN, Varunee; MAN KARMACHARYA, Biraj; THANACHARTWET, Vipa et al.Southeast Asian journal of tropical medicine and public health. 2011, Vol 42, Num 6, pp 1414-1422, issn 0125-1562, 9 p.Article

Disposition of [1'-14C]Stavudine after Oral Administration to HumansLIAN ZHOU; KAUL, Sanjeev; LIU-KREYCHE, Peggy et al.Drug metabolism and disposition. 2010, Vol 38, Num 4, pp 655-666, issn 0090-9556, 12 p.Article

Drug-resistant mutation patterns in CRF01-AE cases that failed d4T + 3TC + nevirapine fixed-dosed, combination treatment: Follow-up study from the Lampang cohortSAENG-AROON, Siriphan; TSUCHIYA, Naho; AUWANIT, Wattana et al.Antiviral research. 2010, Vol 87, Num 1, pp 22-29, issn 0166-3542, 8 p.Article

Clinical Evaluation of Local Ocular Toxicity in Candidate Anti-Adenoviral Agents in vivoINOUE, Hirotoshi; SONODA, Koh-Hei; ISHIKAWA, Makoto et al.Ophthalmologica (Basel). 2009, Vol 223, Num 4, pp 233-238, issn 0030-3755, 6 p.Article

Simultaneous Determination of Zalcitabine and Stavudine in Maternal Plasma, Amniotic Fluid, Placental, and Fetal Tissues Using Reversed Phase on Silica Liquid Chromatography/Tandem Mass SpectrometryMENG XU; WHITE, Catherine A; BARTLETT, Michael G et al.Journal of liquid chromatography & related technologies. 2009, Vol 32, Num 5-8, pp 680-697, issn 1082-6076, 18 p.Article

  • Page / 21